Atara Biotherapeutics, Inc.
ATRA· Nasdaq
Released Mar 1, 2021, after the close
10-K filed Mar 1, 2021, 60 days after period end · 0001564590-21-009854
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$81.31M | -$78.50M | -$80.01M | -$35.31M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Atara Biotherapeutics, Inc. · CIK 1604464 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2020 · filed Mar 1, 2021 · 60 d after period end
6.8% from the close of Mar 1, 2021 to the close of Mar 3, 2021, the first after the release.